# A Study of ASKG315 in Patients With Advanced Solid Tumors.

> **NCT05554666** · PHASE1 · UNKNOWN · sponsor: **AskGene Pharma, Inc.** · enrollment: 56 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** ASKG315

## Key facts

- **NCT ID:** NCT05554666
- **Lead sponsor:** AskGene Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05554666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05554666, "A Study of ASKG315 in Patients With Advanced Solid Tumors.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05554666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*